 Connection
Kristine Erlandson to HIV Integrase Inhibitors
This is a "connection" page, showing publications Kristine Erlandson has written about HIV Integrase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.743 |
|
|
|
-
Erlandson KM, Mohaweche R, Morrow M, Mawhinney S, Khuu V, Boyd M, Balasubramanyam A, Melanson EL, Lake JE. Energy balance and body composition after switch between integrase strand transfer inhibitors and doravirine among people with HIV. J Antimicrob Chemother. 2024 01 03; 79(1):179-185.
Score: 0.762
-
Guaraldi G, Milic J, Bacchi E, Carli F, Menozzi M, Franconi I, Raimondi A, Ciusa G, Masi V, Belli M, Guaraldi S, Aprile E, Mancini M, Mussini C, Lake JE, Erlandson KM. Contribution of integrase inhibitor use, body mass index, physical activity and caloric intake to weight gain in people living with HIV. HIV Res Clin Pract. 2022 11 22; 24(1):1-6.
Score: 0.706
-
Erlandson KM, Wu K, Lake JE, Samuels DC, Bares SH, Tassiopoulos K, Koethe JR, Brown TT, Leonard M, Benson CA, Haas DW, Hulgan T. Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy. AIDS. 2021 03 01; 35(3):439-445.
Score: 0.626
-
Lake JE, Wu K, Bares SH, Debroy P, Godfrey C, Koethe JR, McComsey GA, Palella FJ, Tassiopoulos K, Erlandson KM. Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy. Clin Infect Dis. 2020 12 03; 71(9):e471-e477.
Score: 0.616
-
Erlandson KM, Campbell TB. Inflammation in Chronic HIV Infection: What Can We Do? J Infect Dis. 2015 Aug 01; 212(3):339-42.
Score: 0.409
-
Kousari AE, Wilson MP, Hawkins KL, Bandali MM, Henao-MartÃnez AF, Gardner EM, Erlandson KM. Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV. HIV Res Clin Pract. 2024 12; 25(1):2339576.
Score: 0.196
-
O'Halloran JA, Parra-Rodriguez L, Goss CW, Agarwal M, Cooley S, Wu K, Westerhaus E, Presti R, Ances BM, Tassiopoulos K, Erlandson KM. Impact of Integrase Strand Transfer Inhibitors on Cognition in the HAILO Cohort. J Acquir Immune Defic Syndr. 2023 12 15; 94(5):437-444.
Score: 0.190
-
Wu K, Koethe J, Hulgan T, Brown T, Bares SH, Tassiopoulos K, Lake JE, Leonard M, Samuels DC, Erlandson K, Haas DW. Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens. Pharmacogenet Genomics. 2024 02 01; 34(2):25-32.
Score: 0.188
-
Russo SC, Ockene MW, Arpante AK, Johnson JE, Lee H, Toribio M, Stanley TL, Hadigan CM, Grinspoon SK, Erlandson KM, Fourman LT. Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. AIDS. 2024 10 01; 38(12):1758-1764.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|